MAPK8 and type 2 diabetes mellitus: 7-O-galloyl-d-sedoheptulose can inhibit the activation of NF-κB and AP-1 and plays a key role in liver protection in type 2 diabetes by inhibiting phosphorylation of ERK1/2 and JNK (174).